SCHEMBL18274757

SCHEMBL18274757

O=C(NS(=O)(=O)c1ccc(NCCCN2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3cc(Cl)ccc3-c3ccccc3)CC2)cc1Sc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 15/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958736 0.94 BCL2 (0.79) BCL2
SCHEMBL17681530 0.88 BCL2 (0.68) BCL2
SCHEMBL19424883 0.86 BCL2 (0.66) BCL2
SCHEMBL1956448 0.84 BCL2 (0.80) BCL2
SCHEMBL1958306 0.84 BCL2 (0.79) BCL2
SCHEMBL1957374 0.83 BCL2 (0.97) BCL2
SCHEMBL1956079 0.82 BCL2 (1.00) BCL2
SCHEMBL1957649 0.82 BCL2 (1.00) BCL2
SCHEMBL1956870 0.82 BCL2 (1.00) BCL2
SCHEMBL1956315 0.81 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101019-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES AbbVie Inc. (US) 2016-12-07 — — EP disclosed
Send feedback